Medication Management:
As Unique As You.
Though evidence-based clinical treatment plans can be helpful for some, rarely do they take into account individual nuances such as the patient's work/home life schedule, metabolic side effect risks, trauma histories, or DNA influences on the drug-gene interactions. To explore the latter, we may on occasion recommend Genesight testing which can afford the patient and their provider some "clues" important in medication selection.
Benzodiazepines (eg., clonazepam, lorazepam) are helpful in occasional, "as needed" emergency uses, but are not a first-line or daily use treatment for most presentations of anxiety and or panic. Because of their long-term implications on physical health and cognition, your provider will work with you to explore many other available options and treatment strategies.
IntelliPsych providers believe medication has its role in wellness, but it is not the only path to achieving wellness. Most patients find the combination of medication and psychotherapy to be more condusive to transformative healing.
Foster Wellbeing. Instill Hope.
Heal Collaboratively. Reduce Barriers.
20.3%
of U.S. adults received any mental health treatment in the past 12 months, including 16.5% who had taken prescription medication for their mental health and 10.1% who had received counseling or therapy from a mental health professional. While the percentage of adults who had taken medication for their mental health increased with age, the percentage who had received counseling or therapy decreased with age.
Terlizzi EP, Norris T. Mental health treatment among adults: United States, 2020. NCHS Data Brief, no 419. Hyattsville, MD: National Center for Health Statistics.
60Million
Mental health crises account for 60 million visits to primary care and 6 million ER visits annually. Serious mental illness costs the country more than $190 billion in lost earnings every year.
66.7%
In 2022, among the 15.4 million adults with SMI, 10.2 million (66.7%) received mental health treatment in the preceding year.
Merikangas KR, He JP, Burstein M, Swanson SA, Avenevoli S, Cui L, Benjet C, Georgiades K, Swendsen J. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010 Oct;49(10):980-9.
©Copyright. All rights reserved.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.